Mars Petcare US, Inc. issued a voluntary recall on July 2, 2026, covering two lots of PEDIGREE® Can High Protein Chopped Chicken & Duck Flavor 13.2oz. wet dog food cans PEDIGREE® Update. The company, headquartered in Franklin, Tennessee FDA, said the action was prompted by potential fraudulent distribution of the product rather than a standard manufacturing defect PR Newswire. The FDA's recall listing describes the reason more specifically as potential foreign plastic contamination FDA.

The mechanics behind this recall diverge from the typical contamination narrative. According to reporting from Fox59 and MSN, the affected cans had already failed internal safety checks and were slated for destruction before being diverted and fraudulently sold rather than scrapped Fox59. That distinction matters for how the industry and regulators classify the incident: this is not a production-line failure that slipped past quality control, but a breach in the chain of custody for product that had already been flagged as unfit for sale. Foreign material identified includes sharp metal and plastic pieces, which pose a laceration or obstruction risk if ingested by dogs WebCenterFairbanks.

Mars Petcare has stated that no other Pedigree or Mars Petcare U.S. Inc. products are implicated beyond the two specified actions, a point reiterated as recently as July 7 Fox59 and repeated in earlier July 3 coverage WebCenterFairbanks. The recall notice itself is posted on Pedigree's official site under the /update page, the company's designated channel for consumer-facing safety communications.

This is the second Pedigree recall tied to foreign-material contamination in roughly two years. In May 2024, Mars Petcare voluntarily recalled 315 bags of PEDIGREE® Adult Complete Nutrition Grilled Steak dog food due to potential loose metal contamination, a much narrower action confined to product sold through Walmart locations in Arkansas, Louisiana, Oklahoma, and Texas FDA. That the Hawaii Department of Health was still circulating a public alert referencing metal contamination as late as July 6, 2026 Hawaii DOH suggests state-level food safety offices are treating the two incidents, separated by two years, as part of a continuing pattern worth flagging to consumers even though Mars maintains they are unrelated in scope.

The fraudulent-diversion angle sets this recall apart from the routine product-safety notices that periodically touch the pet food sector. Contamination that originates in manufacturing is a quality-assurance problem with a traceable root cause on the production floor. Contamination introduced after a product has been condemned for destruction is a supply-chain security problem, implicating whoever handled disposal logistics between the point of rejection and the point of resale. For a company the size of Mars Petcare, whose Pedigree line is marketed as an affordable option under the tagline "Bring Out The Good In Your Dog" PEDIGREE®, the reputational exposure of a diversion scheme is arguably sharper than a contamination event confined to a single production run, since it raises questions about custody controls at the destruction or disposal stage rather than about the recipe or the factory.

Pedigree's own marketing emphasizes nutrient-fortified formulation positioned toward health and vitality claims PEDIGREE®, language that sits awkwardly against a recall rooted in circumvented destruction protocols rather than an ingredient failure. Consumers checking lot codes against the /update page are effectively verifying whether cans that were never meant to reach a shelf ended up there anyway.

No injuries or illnesses have been detailed in the available reporting, and the scope remains limited to the two named lots of the canned product. Whether the diversion involved external actors, a third-party disposal contractor, or an internal lapse has not been disclosed publicly. That detail, if it emerges, will likely shape whether this becomes a case study in food-safety enforcement or in supply-chain fraud prevention — two adjacent but distinct regulatory conversations that the FDA and state health departments will need to sort out as the investigation proceeds.